National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
This grant funds early phase clinical trials for cancer treatment and diagnosis.
About this program
The National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials grant supports innovative research aimed at developing new treatments and diagnostic methods for cancer. This program is designed for researchers who are looking to conduct clinical trials that will advance the understanding and treatment of cancer. The funding is intended to facilitate the initiation of these trials, which are crucial for translating laboratory discoveries into clinical applications that can benefit patients.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in cancer research. Researchers must have a strong background in clinical trials and cancer research.
Requirements
- Must conduct early phase clinical trials
- Must focus on cancer treatment or diagnosis